Marcia K. Horn is the president and CEO of ICAN, International Cancer Advocacy Network, https://askican.org/ and chair of the Biomarker Collaborative, a pan-tumor global consortium of biomarker specific advocacy organizations.
At ICAN, Marcia is a research advocate who has directly navigated thousands of pan-tumor patient cases in the U.S. and in 83 countries since the founding of the organization in 1996. She is a molecular profiling advocate, a clinical trials matching advocate, an expanded access/compassionate use advocate, a public policy advocate, and a health equity advocate.
Since 2017, Marcia has served as the Executive Director of the Exon 20 Group, https://exon20group.org, an international multi-stakeholder biomarker support group assisting EGFR Exon 20 Warriors and the HER2 Warriors. She chairs the MET Crusaders assisting patients and care partners with MET exon 14 skipping, MET amplification, and MET overexpression. ICAN recently announced the formation of the NRG1 Energizers, which assists patients and care partners dealing with NRG1 fusion positive lung, pancreatic, cholangiocarcinoma and other cancers.
Marcia served as one of the two research advocates for the Stand Up 2 Cancer Molecular Early Detection of Colon Cancer Dream Team and the Stand Up 2 Cancer InTIME Dream Team for Lung Cancer Interception. She was chosen as DIA’s inaugural chairman of its Patient Engagement Community and was named one of the first PCORI Ambassadors. Marcia has served for eight years as member of the ASCO TAPUR Study Molecular Tumor Board and has been a member of the Banner Health Institutional Review Board for 13 years. She is the research advocate for the SWOG Early Therapeutics/Rare Cancers Committee and enjoys her role as one of the advocates for the National Cancer Institute’s University of Texas Southwestern/MD Anderson Cancer Center Lung SPORE (Specialized Program of Research Excellence).
Marcia is a Phi Beta Kappa graduate of Stanford University in Political Science and received her JD from the Stanford Law School. Before joining ICAN, she practiced litigation and appellate law in Phoenix and held major leadership positions in the Arizona arts community.